News

See an inside look at how Providence Portland Medical Center’s da Vinci machine helps surgeons provide safer, faster care to patients.

Jim waited until he was 70 to retire from a long and fulfilling career. Then he was diagnosed with lung cancer—twice.

A medication designed to block and break down the androgen receptor, a key driver of prostate cancer growth, is being evaluated in a clinical trial at Providence Cancer Institute.

Get a behind the scenes peek into the work of a cancer research administrator as she reflects on her time at Providence Cancer Institute.

Robotic thoracic surgery is less invasive, allowing patients to recover more quickly. A Providence Cancer Institute surgeon calls it a game-changer.

Hands-on experience in a laboratory at Providence Cancer Institute helps undergraduate students find their career path in biomedical fields.

Learn key facts about lung cancer at a free virtual talk hosted by Providence Cancer Institute and Asian Cancer Resource & Support Services.

A new medication developed at Providence Cancer Institute is being evaluated in a clinical trial for people with advanced cancers.

A phase III clinical trial for people with HR+ HER2- breast cancer aims to extend survival and improve patients’ quality of life.

What surprised Molly most about cold cap therapy is that she didn’t lose her hair during treatment for breast cancer.

Expert voices in immuno-oncology from inside and outside Providence gather for a day of thought-provoking discussion, discovery and collaboration.

Explore new findings in cancer immunotherapy and clinical research from Providence at ASCO 2025.